Sinus node inhibitors provide insight into cardiac mechanisms Newsletter Article 16 February 2013 Pages: 2 - 2
Modelling the cost-utility of breast cancer treatment Jo Fitz-Gerald Newsletter Article 16 February 2013 Pages: 3 - 4
Attenuated vaccine against AIDS deserves reconsideration Newsletter Article 16 February 2013 Pages: 5 - 5
QOL impact of didanosine vs zidovudine in HIV infection Newsletter Article 16 February 2013 Pages: 6 - 6
Surgery more cost effective for gastro-oesophageal reflux Newsletter Article 16 February 2013 Pages: 6 - 6
Oral clarithromycin cuts the cost of treating pneumonia Jill Stein Newsletter Article 16 February 2013 Pages: 7 - 7
Diclofenac/hyaluronic acid gel treats breakthrough pain in OA Newsletter Article 16 February 2013 Pages: 8 - 8
Loviride increases CD4+ cell counts in patients with HIV-1 Newsletter Article 16 February 2013 Pages: 8 - 8
Stroke studies lead to new era for thrombolytic therapy Robert H. Carlson Newsletter Article 16 February 2013 Pages: 9 - 10
PFP-2 vaccine fights RSV illness in children with cystic fibrosis Newsletter Article 16 February 2013 Pages: 11 - 11
MBP analogue effective in experimental encephalomyelitis Newsletter Article 16 February 2013 Pages: 11 - 11
Artemether superior to quinine in severe falciparum malaria Newsletter Article 16 February 2013 Pages: 12 - 12
Developmental gap eliminated in severe congenital hypothyroidism Newsletter Article 16 February 2013 Pages: 13 - 13
Botulinum toxin an option for non-dystonic tremors Newsletter Article 16 February 2013 Pages: 15 - 15
Calcium antagonists vs ACE inhibitors in polycystic kidney disease Newsletter Article 16 February 2013 Pages: 15 - 15
Ropivacaine provides effective extradural analgesia in labour Newsletter Article 16 February 2013 Pages: 15 - 15
Cefpodoxime proxetil: once-daily administration effective Newsletter Article 16 February 2013 Pages: 15 - 15
Combination therapy better for control of recurrent CMV retinitis Newsletter Article 16 February 2013 Pages: 16 - 16
Wegener’s granulomatosis: initial phase responds to cotrimoxazole Newsletter Article 16 February 2013 Pages: 16 - 16
Factors predicting mefloquine treatment failure in malaria Newsletter Article 16 February 2013 Pages: 17 - 17
Should second-line agents be continued long term in RA? Newsletter Article 16 February 2013 Pages: 17 - 17
3 ACE inhibitor/diuretic regimens bioequivalent in hypertension Newsletter Article 16 February 2013 Pages: 18 - 18
Not safe to stop antifungals for coccidioidal meningitis Newsletter Article 16 February 2013 Pages: 18 - 18
Onychomycosis: 1-week pulses of itraconazole ‘very good’ Newsletter Article 16 February 2013 Pages: 19 - 19
Low cyanocobalamin levels linked to impaired vaccine response Newsletter Article 16 February 2013 Pages: 19 - 19
Midazolam plasma clearance variable in critically ill children Newsletter Article 16 February 2013 Pages: 20 - 20